Advertisement

A Comparison of Quality Outcome Measures in Patients Having a Hysterectomy for Benign Disease: Robotic vs. Non-robotic Approaches

Published:October 28, 2013DOI:https://doi.org/10.1016/j.jmig.2013.10.008

      Abstract

      Study Objective

      To measure procedure-related hospital readmissions within 30 days after discharge for patients who have a hysterectomy for benign disease. Secondary outcome quality measures evaluated were cost, estimated blood loss, length of stay and sum of costs associated with readmissions.

      Design

      Retrospective cohort study (Canadian Task Force classification II-2).

      Setting

      Academic community hospital.

      Patients

      Patients who underwent hysterectomy to treat benign disease from January 2008 to December 2012.

      Interventions

      Patients were grouped according to route of hysterectomy: robotic-assisted laparoscopic hysterectomy (robotic), laparoscopic hysterectomy (laparoscopic), abdominal hysterectomy (open via laparotomy), and vaginal hysterectomy (vaginal).

      Measurements and Main Results

      Inclusion criteria were met by 2554 patients: 601 in the robotic group, 427 in the laparoscopic group, 1194 in the abdominal group, and 332 in the vaginal group. Readmission rates in the robotic cohort were significantly less (p<.05) than in non-robotic cohorts: Robotic (1%), laparoscopic (2.5%), open (3.5%), vaginal (2.4%). Estimated blood loss, length of stay, and sum of readmission costs were also significantly less in the robotic cohort (p<.05) compared with the other 3 cohorts.

      Conclusion

      Patients who undergo robotic-assisted laparoscopic hysterectomy have a significantly lower chance of readmission <30 days after surgery compared with those who undergo laparoscopic, abdominal (open) hysterectomy, and vaginal approaches. Patients in the robotics cohort also experienced a shorter length of stay, less estimated blood loss, and a cost savings associated with readmissions when compared to non-robotic approaches. Prospective registries describing quality outcomes, total sum of costs including 30 days follow-up, as well as patient-related quality of life benefits are recommended to confirm these findings and determine which surgical route offers the highest patient and societal value.

      Keywords

      To read this article in full you will need to make a payment
      AAGL Member Login
      AAGL Member, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hackbarth G.
        • Reischauer R.
        • Mutti A.
        Collective accountability for medical care: toward bundled Medicare payments.
        N Engl J Med. 2008; 359: 3-5
        • Henretta M.S.
        • Scaliici J.M.
        • Engelhard C.L.
        • Duska M.S.
        The revolving door: hospital readmissions of gynecologic oncology patients.
        Gynecol Oncol. 2011; 122: 479-483
        • Epstein A.M.
        Revisiting readmission: changing the incentives for shared accountability.
        N Engl J Med. 2009; 360: 1457-1459
        • Jencks S.F.
        • Williams M.V.
        • Coleman E.A.
        Rehospitalization among patients in the Medicare fee-for-service program.
        N Engl J Med. 2009; 360: 1418-1428
        • Jacobson G.F.
        • Shaber R.E.
        • Armstrong M.A.
        • Hung Y.Y.
        Hysterectomy rates for benign indications.
        Obstet Gynecol. 2006; 107: 1278-1283
        • Warren L.
        • Ladapo J.A.
        • Borah B.J.
        • Gunnarson C.L.
        Open abdominal versus laparoscopic and vaginal hysterectomy: analysis of a large United States payer measuring quality and cost of care.
        J Minim Invasive Gynecol. 2009; 16: 581-588
        • Wright J.D.
        • Anath C.V.
        • Lewin S.N.
        • et al.
        Robotically assisted vs laparo-scopic hysterectomy among women with benign gynecologic disease.
        JAMA. 2013; 309: 689-698
        • Elixhauser A.
        • Steiner C.
        • Harris D.R.
        • Coffey R.M.
        Comorbidity Measures for Use with Administrative Data.
        Medical Care. 1998; 36: 8-27
        • American College of Obstetricians and Gynecologists
        Choosing the route of hysterectomy for benign disease. ACOG Committee Opinion No. 444.
        Obstet Gynecol. 2009; 114: 1156-1158
        • Adeyemo D.
        • Radley S.
        Unplanned general surgical re-admission: how many, which patients and why?.
        Ann R Coll Surg Engl. 2007; 89: 363-367